| 摘要 |
Disclosed is the use of a substance P receptor antagonist for the preparation of a medicament for the treatment of brain, spinal cord and nerve injury, for the improvement of cognitive outcome after brain injury, for preventing substance P induced deficits in learning and memory after brain injury, for the improvement of motor and cognitive outcome in mild to severe brain injury, the reduction of blood brain barrier permeability, for the reduction of formation of vasogenic oedema or for the prevention of acute water accumulation in the brain after injury. (62) Divided out of 519990 |
